Omada Health, Inc. (OMDA)
Healthcare • Health Information Services
StockNasdaqGSUnited StatesUS68170A1088
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Omada Health, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 14:02. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 04 Mar 2027 16:00 | 0.13 | — | — | Upcoming |
| 05 Nov 2026 16:00 | 0.10 | 0.21 | +114.3% | Beat |
| 06 Aug 2026 16:00 | 0.06 | 0.20 | +219.8% | Beat |
| 07 May 2026 16:00 | -0.04 | 0.05 | +209.9% | Beat |
| 05 Mar 2026 16:00 | 0.03 | 0.16 | +440.3% | Beat |
| 06 Nov 2025 16:00 | -0.07 | 0.03 | +142.6% | Beat |
| 07 Aug 2025 16:00 | -0.13 | -0.05 | +59.1% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 260.2M | +53.2% | -12.8M | -4.9% | -0.35 | +58.6% | 12.4M |
| 2024 | 169.8M | +38.3% | -47.1M | -27.8% | -0.85 | +40.2% | -38M |
| 2023 | 122.8M | +37.7% | -67.5M | -55.0% | -1.41 | +6.9% | -52.7M |
| 2022 | 89.2M | — | -72.5M | -81.3% | -1.52 | — | -71.7M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 12 Nov 2026 In progress | 15.26 | 15.63 | 14.33 | 14.70 | -2.58% | 6,397,500 | |
| 02 Nov 2026 – 06 Nov 2026 | 18.91 | 19.91 | 14.75 | 15.09 | -19.43% | 9,365,800 | |
| 26 Oct 2026 – 30 Oct 2026 | 19.03 | 19.70 | 18.47 | 18.73 | -1.16% | 3,677,200 | |
| 19 Oct 2026 – 23 Oct 2026 | 17.72 | 19.80 | 17.69 | 18.95 | +7.49% | 4,631,900 | |
| 12 Oct 2026 – 16 Oct 2026 | 21.66 | 22.00 | 17.48 | 17.63 | -18.19% | 7,496,500 | |
| 05 Oct 2026 – 09 Oct 2026 | 20.44 | 21.59 | 20.07 | 21.55 | +5.79% | 4,630,000 | |
| 28 Sep 2026 – 02 Oct 2026 | 19.60 | 21.08 | 18.68 | 20.37 | +3.61% | 7,822,200 | |
| 21 Sep 2026 – 25 Sep 2026 | 20.42 | 21.52 | 19.63 | 19.66 | -3.77% | 4,656,100 | |
| 14 Sep 2026 – 18 Sep 2026 | 19.95 | 21.09 | 19.54 | 20.43 | +3.92% | 11,577,200 | |
| 08 Sep 2026 – 11 Sep 2026 | 22.43 | 22.79 | 19.31 | 19.66 | -13.66% | 5,423,000 | |
| 66 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Omada: 3 Key Takeaways for Long-Term Investors (opens in a new tab) Motley Fool · 09 Nov 2026 01:39
- Omada Health, Inc. (OMDA) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 08 Nov 2026 22:54
- What Changes For Omada Health (OMDA) As It Names A New CEO? (opens in a new tab) Simply Wall St. · 08 Nov 2026 11:16
- Omada Health (OMDA) Stock May Be Fully Priced Following Raised Guidance (opens in a new tab) Simply Wall St. · 08 Nov 2026 10:10
- Omada Health (OMDA) Dropped, So What Is Behind The Attention Now? (opens in a new tab) Simply Wall St. · 08 Nov 2026 04:21
- Omada Health (OMDA) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 06 Nov 2026 17:58
- Unusual Options Volume Report: 3 Stocks Moving After Earnings (opens in a new tab) Schaeffer's Investment Research · 06 Nov 2026 16:45
- Omada Health Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 06 Nov 2026 13:30
- What Omada Health (OMDA) Said on Its Q3 Earnings Call (opens in a new tab) MarketBeat · 06 Nov 2026 13:14
- Barclays Maintains Overweight on Omada Health, Lowers Price Target to $22 (opens in a new tab) Benzinga · 06 Nov 2026 12:26
- Wells Fargo Maintains Equal-Weight on Omada Health, Lowers Price Target to $19 (opens in a new tab) Benzinga · 06 Nov 2026 10:39
- Omada Health Inc (OMDA) (Q3 2026) Earnings Call Highlights: Record Revenue, Membership Growth, ... (opens in a new tab) GuruFocus.com · 06 Nov 2026 07:22
- Compared to Estimates, Omada Health, Inc. (OMDA) Q3 Earnings: A Look at Key Metrics (opens in a new tab) Zacks · 05 Nov 2026 22:30
- Omada Health, Inc. (OMDA) Q3 Earnings and Revenues Beat Estimates (opens in a new tab) Zacks · 05 Nov 2026 21:45
- Omada Health Reports Third Quarter 2026 Results (opens in a new tab) 05 Nov 2026 21:02
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 15.24 USD
- Market cap
- 916.3M
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Health Information Services
- Currency
- USD
Dividends
No dividends on record.
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 25.0 / 25 |
|
| Quality Return on equity, net margin and how stable the margins are. | 1.2 / 25 |
|
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 12.0 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 5.2 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 10.0 / 10 |
|
- Score capped at 60: free cash flow was negative in two of the last three years
- Thin interest cover: operating profit is only -4.7× the interest
- The last full year was a loss
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A). Warnings take 12 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 38.1× | Weak | 30.56× |
| P/E (forward) | 22.94× | Fair | 14.16× |
| Price / book | 3.46× | Weak | 3.5× |
| Price / sales | 2.84× | Fair | 3.33× |
| EV / EBITDA | 53.67× | Weak | 11.19× |
| Free cash flow yield | 1.8% | Weak | 2.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 70.7% | Good | 54.9% |
| Operating margin | 2.1% | Weak | 5.8% |
| Net margin | 4.2% | Weak | 1.2% |
| Return on equity | 5.7% | Weak | 4.4% |
| Return on assets | 1.4% | Weak | 2.7% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 42.9% | Good | 10.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0× | Good | 0.4× |
| Net debt / EBITDA | -18.58× | Good | 1.46× |
| Interest cover | -4.72× | Weak | 2.17× |
| Current ratio | 4.18× | Good | 2.64× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 0% | Weak | 0% |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Similar shares
Follow OMDA and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.